June 30, 2026

AI Tool Finds More Long COVID Cases Than Codes

Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.

Conexiant

June 30, 2026

How Does Social Media Influence Health Decisions?

National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.

Conexiant

June 30, 2026

Mass Spec Roundup: Hidden Origins and Cellular States

New studies separate host and microbial metabolites, trace secreted proteins, identify a pro-regenerative cardiomyocyte state, and map macrophage lipid metabolism

The Analytical Scientist

June 29, 2026

FDA Approves New Treatment for Thyroid Eye Disease

Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.

Conexiant

June 29, 2026

Side Effects: The Gut Goes Rogue

When fiber metabolism falters in lupus, the microbiome may start dining on the host instead. This week: mucin-munching bugs, brain-delivered DHA with no cognitive payoff, and lipid-loaded MS lesions that may not be innocent bystanders.

Conexiant

June 29, 2026

Metabolic Health Tied to Dementia

In two population-based cohorts, metabolically unhealthy status generally showed higher dementia risk estimates, while metabolically healthy obesity was not associated with increased risk in primary analyses.

Conexiant

June 29, 2026

Pregnancy Health Score Tied to Later Cardiometabolic Risk

A modified cardiovascular health score during pregnancy was associated with later diagnosis of chronic hypertensive and metabolic conditions.

Conexiant

June 28, 2026

Blindness Linked to Higher Loneliness Scores

Analysis of more than 61,000 patients found higher odds of elevated loneliness scores among those reporting blindness and those with diabetic retinopathy, but not among patients with glaucoma or age-related macular degeneration.

Conexiant

June 27, 2026

GLP-1 Drugs Tied to Smell, Taste Changes

A matched electronic health record study of more than 876,000 patients with type 2 diabetes found a low absolute incidence but higher relative hazard of documented smell and taste disturbances among patients prescribed glucagon-like peptide-1 receptor agonists.

Conexiant

June 27, 2026

GLP-1 RAs May Ease Psoriasis, PsA Data Limited

Published evidence linked liraglutide and semaglutide to improvements in psoriasis severity, inflammatory markers, and metabolic outcomes, while evidence in psoriatic arthritis remained sparse.

Conexiant